Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: To investigate the association of prescript...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA
Hauptverfasser: Inohara, Taku, Manandhar, Pratik, Kosinski, Andrzej S., Matsouaka, Roland A., Kohsaka, Shun, Mentz, Robert J., Thourani, Vinod H., Carroll, John D., Kirtane, Ajay J., Bavaria, Joseph E., Cohen, David J., Kiefer, Todd L., Gaca, Jeffrey G., Kapadia, Samir R., Peterson, Eric D., Vemulapalli, Sreekanth
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2018
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583475/
https://ncbi.nlm.nih.gov/pubmed/30512100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18077
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge